Hsbc Global Res Upgrades Coloplast A/S (OTCMKTS:CLPBY) to “Hold”

Hsbc Global Res upgraded shares of Coloplast A/S (OTCMKTS:CLPBY) from a moderate sell rating to a hold rating in a research note published on Monday morning,Zacks.com reports.

Coloplast A/S Stock Down 1.2 %

Shares of CLPBY opened at $12.60 on Monday. The business’s 50 day simple moving average is $13.07 and its 200-day simple moving average is $12.86. Coloplast A/S has a 1 year low of $10.69 and a 1 year high of $14.34. The company has a quick ratio of 0.56, a current ratio of 0.85 and a debt-to-equity ratio of 1.00.

Coloplast A/S (OTCMKTS:CLPBY) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $0.08 EPS for the quarter. Coloplast A/S had a net margin of 18.69% and a return on equity of 31.17%. The business had revenue of $1.02 billion during the quarter. Equities research analysts anticipate that Coloplast A/S will post 0.38 EPS for the current year.

Coloplast A/S Increases Dividend

The business also recently announced a dividend, which will be paid on Friday, December 20th. Stockholders of record on Monday, December 9th will be issued a $0.2435 dividend. This is a boost from Coloplast A/S’s previous dividend of $0.05. The ex-dividend date of this dividend is Monday, December 9th. Coloplast A/S’s payout ratio is 27.27%.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.